NVSEF - Novartis AG (NVS) Q4 2023 Earnings Call Transcript
2024-01-31 12:39:03 ET
Novartis AG (NVS)
Q4 2023 Earnings Conference Call
January 31, 2024 08:00 AM ET
Company Participants
Samir Shah - Global Head of Investor Relations
Vas Narasimhan - Chief Executive Officer
Harry Kirsch - Chief Financial Officer
Conference Call Participants
Matthew Weston - UBS
Andrew Baum - Citi
Florent Cespedes - Societe Generale
Graham Parry - Bank of America
John Priestner - JPMorgan
Tim Anderson - Wolfe Research
Simon Baker - Redburn
Kerry Holford - Berenberg
Seamus Fernandez - Guggenheim Securities
Emily Field - Barclays
Peter Welford - Jefferies
Richard Parkes - BNP Paribas
Mark Purcell - Morgan Stanley
Stephen Scala - TD Cowen
Presentation
Operator
Good morning, and good afternoon, and welcome to the Novartis Q4 2023 Results Release Conference Call and Live Webcast. Please note, that during the presentation all participants will be in a listen-only mode and the conference is being recorded. [Operator Instructions] Please limit yourselves to one question and return to the queue for any follow-up. A recording of the conference call, including the Q&A session will be available on our website shortly after the call ends.
With that, I would like to hand over to Mr. Samir Shah, Global Head of Investor Relations. Please go ahead, sir.
Samir Shah
Thank you very much, and good morning, and good afternoon, everybody. Thank you again for listening to our full year results and Q4 results.
The information presented today contains forward-looking statements that involve known and unknown risks, uncertainties, and other factors. These may cause the actual results to be materially different from any future results, performance, or achievements expressed or implied by such statements. For a description of some of these factors, please refer to the company's Form 20-F and its most recent quarterly results on Form 6-K that respectively were filed with and furnished to the U.S. Securities and Exchange Commission.
And with that, I'll hand it across to Vas.
Vas Narasimhan
Thank you, Samir, and thanks everyone for joining today's call. I know it's a busy day with many companies reading out, but we hope to provide you some insights into our Q4 2023 results and also some perspectives on the outlook for Novartis in 2024 and beyond.
If we move to the first slide, Slide 4. As you saw in our earnings release this morning, we delivered a strong full year performance with margin expansion and strong innovation momentum with 10 positive Phase III readouts over the course of 2023. As a reminder, our full year guidance at the start of the year was quite a bit lower than where we ended up and we had multiple earnings upgrades over the course of the year demonstrating, I think, the strong business momentum we have at the company....
Novartis AG (NVS) Q4 2023 Earnings Call Transcript